Medical Industry Feature: The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)

The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)

The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)
RestartResume
Dr. Matt Birnholz and Dr. Nicole Lamanna discuss Chronic Lymphocytic Leukemia (CLL): how it's characterized, diagnosed, and tested.
  • Overview

    In this program, Dr. Matt Birnholz is joined by Dr. Nicole Lamanna, Associate Professor of Medicine in the Hematologic Malignancies Section at Columbia University Medical Center, New York to discuss Chronic Lymphocytic Leukemia (CLL), the role of clonal evolution and deletion 17p in CLL, and how this disease is characterized, diagnosed and tested.

    This module is intended for United States and Puerto Rico health care professionals only and was developed by Abbvie.

NEW FEATURES:

Register

Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now